Senseonics (NYSEMKT: SENS)
Senseonics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Senseonics Company Info
Senseonics Holdings, Inc. engages in the design, development, and commercialization of an implantable continuous glucose monitoring system for people with diabetes. Its primary product is the brand Eversense, a glucose monitoring device which includes sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.
News & Analysis
Why Senseonics Holdings Stock Popped This Week
Investors appear to be betting that a key regulatory approval is close at hand.
Why Shares of Senseonics Soared 30.6% in August
The maker of continuous glucose monitoring systems for diabetes treatment is a meme stock with some fundamental support.
Why Senseonics Skyrocketed 340% in the First Half of 2021
The maker of continuous glucose-monitoring systems had several positive developments.
2 Robinhood Stocks Wall Street Predicts Will Plunge More Than 25%
But are analysts' pessimistic predictions likely to be right?
Why Senseonics Holdings Popped by Nearly 11% Today
WallStreetBets strikes again!
Here's Why Senseonics Stock Skyrocketed Today
The healthcare specialist's innovative sensors could help people with diabetes better manage their health.
The Only 2 Robinhood Stocks Under $5 I'd Even Consider Buying Right Now
It's not because of their low share prices.
Can This Popular Reddit Stock Make You Rich?
Up over 250% in less than a year, what's behind the rise of this hot stock?
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.